What is Radix Biosolutions?
Radix Biosolutions specializes in the development and production of custom microsphere-based assay products. Leveraging over 14 years of combined experience in Luminex xMAP Platform assay development and extensive research background in pharmaceutical and agricultural industries, the company provides tailored solutions for clients in the research community, drug discovery, and agricultural sectors. Their focus on the Luminex xMAP Platform allows for the efficient, accurate, and economical simultaneous performance of multiple biomolecular reactions on a single test sample.
How much funding has Radix Biosolutions raised?
Radix Biosolutions has raised a total of $139K across 1 funding round:
Debt
$139K
Debt (2021): $139K with participation from PPP
Key Investors in Radix Biosolutions
PPP
Public-Private Partnership
What's next for Radix Biosolutions?
With its large-scale late-stage funding, Radix Biosolutions is poised to accelerate its product development pipeline and expand its market reach. The strategic investment signals confidence from backers in the company's proprietary technology and its ability to capture a significant share of the custom assay market. Future initiatives are likely to focus on scaling production capabilities, enhancing R&D for novel assay applications, and forging deeper partnerships within the drug discovery and agricultural biotechnology industries.
See full Radix Biosolutions company page
